230 related articles for article (PubMed ID: 20810130)
1. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
[TBL] [Abstract][Full Text] [Related]
2. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
3. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
[TBL] [Abstract][Full Text] [Related]
5. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
[TBL] [Abstract][Full Text] [Related]
6. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
[TBL] [Abstract][Full Text] [Related]
8. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
11. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
13. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
Imrell K; Greiner E; Hillert J; Masterman T
J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
[TBL] [Abstract][Full Text] [Related]
17. [The relation between the HLA-DRB1*1501 allele and the severity of multiple sclerosis in a sample of the Spanish population from the Balearic Islands: the influence exerted by sex].
Zabay-Becerril JM; Burcet-Dardé J; Mulet-Ferrer J; Soler-Farré J; Viader-Farré C
Rev Neurol; 2004 Jan 16-31; 38(2):118-22. PubMed ID: 14752708
[TBL] [Abstract][Full Text] [Related]
18. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1 and month of birth in multiple sclerosis.
Ramagopalan SV; Link J; Byrnes JK; Dyment DA; Giovannoni G; Hintzen RQ; Sundqvist E; Kockum I; Smestad C; Lie BA; Harbo HF; Padyukov L; Alfredsson L; Olsson T; Sadovnick AD; Hillert J; Ebers GC
Neurology; 2009 Dec; 73(24):2107-11. PubMed ID: 20018638
[TBL] [Abstract][Full Text] [Related]
20. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
